Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Feb;63(2):334-6.
doi: 10.1002/art.30161.

How does interferon-α insult the vasculature? Let me count the ways

Editorial

How does interferon-α insult the vasculature? Let me count the ways

Mariana J Kaplan et al. Arthritis Rheum. 2011 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399–2406. - PubMed
    1. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331–2337. - PubMed
    1. Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood. 2007;110(8):2907–2915. - PMC - PubMed
    1. Thacker S, Berthier C, Mattinzoli D, Rastaldi MP, Kretzler M, Kaplan MJ. The detrimental effects of Interferon-alpha on vasculogenesis in lupus are mediated by repression of interleukin-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J Immunol. 2010 (in press) - PMC - PubMed
    1. Hua J, Kirou K, Lee C, Crow MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 2006;54(6):1906–1916. - PubMed

MeSH terms

Substances